DEA Launches Improved System for Registered Drug Manufacturers, Distributors to Combat Opioid Epidemic

DEA Launches Improved System for Registered Drug Manufacturers, Distributors to Combat Opioid Epidemic

DEA regulations require distributors to know their customers and develop a system to identify and report orders that seem suspicious. This new tool will help manufacturers and distributors make informed choices about whether new customers are purchasing disproportionate amounts of controlled substances.

The Drug Enforcement Administration announced Tuesday the launch of an improved system to help more than 1,500 registered drug manufacturers and distributors in the U.S. more effectively identify potential illicit drug diversion and work against the opioid epidemic.

In October, President Trump signed into law the “Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.” A provision in the bill requires the DEA to give drug manufacturers and distributors access to anonymized information via the Automated Reports and Consolidated Orders System (ARCOS) to help them identify, report, and stop suspicious orders of opioids and reduce the rate of diversions.

ARCOS is an extensive drug reporting system that monitors the distribution of controlled substances from the point of manufacture through commercial drug supply chain channels to the point of sale to the retail level. ARCOS neither collects nor contains any data on sales to the ultimate users of the substance, i.e. patients.

Last February, DEA launched a new tool in the ARCOS Online Reporting System to help drug manufacturers and distributors fulfill their regulatory obligations under the Controlled Substances Act. The new requirement in the SUPPORT Act improves upon this tool and the administration is releasing a further enhancement to the ARCOS Online Reporting System.

The new enhancement will allow manufacturers and distributors registered with the DEA to view and download the number of distributors and the amount (anonymized data in grams and dosage units) each distributor sold to a prospective customer in the last available six months of data. The resource is part of DEA’s work to collaborate with its 1.8 million registrants to combat the ongoing opioid epidemic in the U.S.

DEA regulations require distributors to know their customers and develop a system to identify and report orders that seem suspicious. This new tool will help manufacturers and distributors make informed choices about whether new customers are purchasing disproportionate amounts of controlled substances by providing valuable information for distributors to consider as part of their assessment.

Download Center

  • EHS Buyer's Guide

    Download this buyer's guide to make more informed decisions as you're looking for an EHS management software system for your organization.

  • Online Safety Training Buyer's Guide

    Use this handy buyer's guide to learn the basics of selecting online safety training and how to use it at your workplace.

  • COVID Return-to-Work Checklist, Fall 2021

    Use this checklist as an aid to help your organization return to work during the COVID-19 pandemic in a safe and healthy manner.

  • SDS Buyer's Guide

    Learn to make informed decisions while searching for SDS Management Software.

  • Risk Matrix Guide

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Industry Safe

Featured Whitepapers

OH&S Digital Edition

  • OHS Magazine Digital Edition - September 2021

    September 2021

    Featuring:

    • COMBUSTIBLE DUST
      Managing Combustible Dust and Risk Mitigation
    • PPE: CONSTRUCTION
      The Rising Popularity of Safety Helmets on the Jobsite
    • PPE: ELECTRICAL SAFETY
      Five Tips for a Successful Wear Trial
    • SAFETY & HEALTH
      Medical Surveillance Versus Medical Screening
    View This Issue